209 related articles for article (PubMed ID: 23766903)
21. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
[TBL] [Abstract][Full Text] [Related]
22. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage.
Veyna RS; Seyfried D; Burke DG; Zimmerman C; Mlynarek M; Nichols V; Marrocco A; Thomas AJ; Mitsias PD; Malik GM
J Neurosurg; 2002 Mar; 96(3):510-4. PubMed ID: 11883835
[TBL] [Abstract][Full Text] [Related]
23. Clinical Burden of Angiographic Vasospasm and Its Complications After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review.
Chalet FX; Briasoulis O; Manalastas EJ; Talbot DA; Thompson JC; Macdonald RL
Neurol Ther; 2023 Apr; 12(2):371-390. PubMed ID: 36609962
[TBL] [Abstract][Full Text] [Related]
24. Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
McGirt MJ; Mavropoulos JC; McGirt LY; Alexander MJ; Friedman AH; Laskowitz DT; Lynch JR
J Neurosurg; 2003 Jun; 98(6):1222-6. PubMed ID: 12816268
[TBL] [Abstract][Full Text] [Related]
25. Emergence of a R-type Ca2+ channel (CaV 2.3) contributes to cerebral artery constriction after subarachnoid hemorrhage.
Ishiguro M; Wellman TL; Honda A; Russell SR; Tranmer BI; Wellman GC
Circ Res; 2005 Mar; 96(4):419-26. PubMed ID: 15692089
[TBL] [Abstract][Full Text] [Related]
26. The relationship between ruptured aneurysm location, subarachnoid hemorrhage clot thickness, and incidence of radiographic or symptomatic vasospasm in patients enrolled in a prospective randomized controlled trial.
Abla AA; Wilson DA; Williamson RW; Nakaji P; McDougall CG; Zabramski JM; Albuquerque FC; Spetzler RF
J Neurosurg; 2014 Feb; 120(2):391-7. PubMed ID: 24313610
[TBL] [Abstract][Full Text] [Related]
27. Acute angiographic vasospasm and the incidence of delayed cerebral vasospasm: preliminary results.
Danura H; Schatlo B; Marbacher S; Kerkeni H; Diepers M; Remonda L; Fathi AR; Fandino J
Acta Neurochir Suppl; 2015; 120():187-90. PubMed ID: 25366622
[TBL] [Abstract][Full Text] [Related]
28. Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis.
Sillberg VA; Wells GA; Perry JJ
Stroke; 2008 Sep; 39(9):2622-6. PubMed ID: 18658040
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Shen J; Shen J; Zhu K; Zhou H; Tian H; Yu G
World Neurosurg; 2019 Nov; 131():e65-e73. PubMed ID: 31295598
[TBL] [Abstract][Full Text] [Related]
30. Cerebral vasospasm as a complication of aneurysmal subarachnoid hemorrhage: a brief review.
Spallone A
Ital J Neurol Sci; 1985 Mar; 6(1):19-26. PubMed ID: 3888914
[TBL] [Abstract][Full Text] [Related]
31. To look beyond vasospasm in aneurysmal subarachnoid haemorrhage.
Cossu G; Messerer M; Oddo M; Daniel RT
Biomed Res Int; 2014; 2014():628597. PubMed ID: 24967389
[TBL] [Abstract][Full Text] [Related]
32. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials.
Shen J; Pan JW; Fan ZX; Xiong XX; Zhan RY
J Neurosurg; 2013 Jul; 119(1):180-9. PubMed ID: 23641823
[TBL] [Abstract][Full Text] [Related]
33. Intravenous magnesium infusion for the prevention of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Jeon JS; Sheen SH; Hwang G; Kang SH; Heo DH; Cho YJ
J Korean Neurosurg Soc; 2012 Aug; 52(2):75-9. PubMed ID: 23091662
[TBL] [Abstract][Full Text] [Related]
34. Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review.
Harrod CG; Bendok BR; Batjer HH
Neurosurgery; 2005 Apr; 56(4):633-54; discussion 633-54. PubMed ID: 15792502
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.
Westermaier T; Stetter C; Vince GH; Pham M; Tejon JP; Eriskat J; Kunze E; Matthies C; Ernestus RI; Solymosi L; Roosen K
Crit Care Med; 2010 May; 38(5):1284-90. PubMed ID: 20228677
[TBL] [Abstract][Full Text] [Related]
36. Transcranial Doppler Sonography Defined Vasospasm, Ischemic Brain Lesions, and Delayed Ischemic Neurological Deficit in Younger and Elderly Patients after Aneurysmal Subarachnoid Hemorrhage.
Bender M; Richter E; Schwarm FP; Kolodziej MA; Uhl E; Reinges MHT; Stein M
World Neurosurg; 2020 Jun; 138():e718-e724. PubMed ID: 32198122
[TBL] [Abstract][Full Text] [Related]
37. The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage.
Yahia AM; Kirmani JF; Qureshi AI; Guterman LR; Hopkins LN
Neurocrit Care; 2005; 3(1):16-23. PubMed ID: 16159090
[TBL] [Abstract][Full Text] [Related]
38. Magnesium in aneurysmal subarachnoid hemorrhage (MASH II) phase III clinical trial MASH-II study group.
Dorhout Mees SM;
Int J Stroke; 2008 Feb; 3(1):63-5. PubMed ID: 18705917
[TBL] [Abstract][Full Text] [Related]
39. Subarachnoid haemorrhage: what happens to the cerebral arteries?
Sobey CG; Faraci FM
Clin Exp Pharmacol Physiol; 1998 Nov; 25(11):867-76. PubMed ID: 9807657
[TBL] [Abstract][Full Text] [Related]
40. Inhalational Versus Intravenous Anesthetic Conditioning for Subarachnoid Hemorrhage-Induced Delayed Cerebral Ischemia.
Athiraman U; Lele AV; Karanikolas M; Dhulipala VB; Jayaraman K; Fong C; Kentner R; Sheolal R; Vellimana A; Gidday JM; Dhar R; Zipfel GJ
Stroke; 2022 Mar; 53(3):904-912. PubMed ID: 34732071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
